Androgel's owner Solvay to launch oral testosterone product.

"Solvay Pharmaceuticals Inc. inked a license agreement with Lipocine Inc. that gives it exclusive rights to develop and commercialize an oral formulation of testosterone."

“This agreement further demonstrates Solvay Pharmaceuticals’ commitment to men suffering from low testosterone,” said Stephen Hill, president of Solvay Pharmaceuticals, in a statement. “As the market leader in the field, we will apply our expertise in the treatment of low testosterone to the development of an oral testosterone replacement therapy. This compound has the potential to be the next major innovation in the management of low testosterone.”

"The new testosterone pill uses Lipocine’s proprietary oral Lip’ral technology. Lip’ral is a clinically proven oral delivery technology for water insoluble drugs."

"Lip’ral technology is based on lipidic compositions which form the optimal dispersed phase in the gastrointestinal environment for improved absorption of the insoluble drug. Lip’ral presents insoluble drugs efficiently to the intestinal absorption site, thus bringing the absorption process under formulation control and making the product robust to physiological variables such as dilution, pH, and food effects."

We expect this new product to be a once a day oral formula, making it nice and easy to abuse unlike Androgel, where the surface area of your skin and the potential mess prevented using a nice high dosage. The downside of this product will of course be it's price I would expect an MRSP of several hundred $ a month ( when used just once a day ) making it far more expensive than good old testosterone injections for muscle building purposes.

No comments:

Post a Comment